KALA BIO, INC. Operating Lease, Payments
KALA BIO, INC. (KALA) reported Operating Lease, Payments of $550.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-04-15
- KALA BIO, INC. operating lease, payments for the quarter ending 2025-12-31 was $102.00K, a 31.08% decline year-over-year.
- KALA BIO, INC. operating lease, payments for the quarter ending 2025-09-30 was $153.00K, a 3.38% increase year-over-year.
- KALA BIO, INC. operating lease, payments for the quarter ending 2025-06-30 was $147.00K, a 3.52% increase year-over-year.
- KALA BIO, INC. operating lease, payments for the quarter ending 2025-03-31 was $148.00K, a 3.50% increase year-over-year.
- KALA BIO, INC. operating lease, payments for fiscal 2025 was $550.00K, a 5.34% decline from fiscal 2024.
- KALA BIO, INC. operating lease, payments for fiscal 2024 was $581.00K, a 186.21% increase from fiscal 2023.
- KALA BIO, INC. operating lease, payments for fiscal 2023 was $203.00K, a 84.60% decline from fiscal 2022.
- KALA BIO, INC. operating lease, payments for fiscal 2022 was $1.32M, a 82.07% decline from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month | Operating Lease, Payments 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $102.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $255.00K derived: sum of 2 quarters · filed 2026-04-15 | $402.00K derived: sum of 3 quarters · filed 2026-04-15 | $550.00K 10-K · filed 2026-04-15 | |
| 2025-09-30 | $153.00K 10-Q · filed 2025-11-19 | $300.00K derived: sum of 2 quarters · filed 2025-11-19 | $448.00K 10-Q · filed 2025-11-19 | $596.00K derived: sum of 4 quarters · filed 2026-04-15 | |
| 2025-06-30 | $147.00K 10-Q · filed 2025-08-08 | $295.00K 10-Q · filed 2025-08-08 | $443.00K derived: sum of 3 quarters · filed 2026-04-15 | $591.00K derived: sum of 4 quarters · filed 2026-04-15 | |
| 2025-03-31 | $148.00K 10-Q · filed 2025-05-14 | $296.00K derived: sum of 2 quarters · filed 2026-04-15 | $444.00K derived: sum of 3 quarters · filed 2026-04-15 | $586.00K derived: sum of 4 quarters · filed 2026-04-15 | |
| 2024-12-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $296.00K derived: sum of 2 quarters · filed 2026-04-15 | $438.00K derived: sum of 3 quarters · filed 2026-04-15 | $581.00K 10-K · filed 2026-04-15 | |
| 2024-09-30 | $148.00K 10-Q · filed 2025-11-19 | $290.00K derived: sum of 2 quarters · filed 2025-11-19 | $433.00K 10-Q · filed 2025-11-19 | $575.00K derived: sum of 4 quarters · filed 2025-11-19 | |
| 2024-06-30 | $142.00K 10-Q · filed 2025-08-08 | $285.00K 10-Q · filed 2025-08-08 | $427.00K derived: sum of 3 quarters · filed 2025-08-08 | $475.00K derived: sum of 4 quarters · filed 2025-08-08 | |
| 2024-03-31 | $143.00K 10-Q · filed 2025-05-14 | $285.00K derived: sum of 2 quarters · filed 2025-05-14 | $333.00K derived: sum of 3 quarters · filed 2025-05-14 | $336.00K derived: sum of 4 quarters · filed 2025-05-14 | |
| 2023-12-31 | $142.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $190.00K derived: sum of 2 quarters · filed 2025-03-31 | $193.00K derived: sum of 3 quarters · filed 2025-03-31 | $203.00K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $48.00K 10-Q · filed 2024-11-12 | $51.00K derived: sum of 2 quarters · filed 2024-11-12 | $61.00K 10-Q · filed 2024-11-12 | $71.00K derived: sum of 4 quarters · filed 2024-11-12 | |
| 2023-06-30 | $3.00K 10-Q · filed 2024-08-06 | $13.00K 10-Q · filed 2024-08-06 | $23.00K derived: sum of 3 quarters · filed 2024-08-06 | $361.00K derived: sum of 4 quarters · filed 2024-08-06 | |
| 2023-03-31 | $10.00K 10-Q · filed 2024-05-14 | $20.00K derived: sum of 2 quarters · filed 2024-05-14 | $358.00K derived: sum of 3 quarters · filed 2024-05-14 | $609.00K derived: sum of 4 quarters · filed 2024-05-14 | |
| 2022-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $348.00K derived: sum of 2 quarters · filed 2024-03-29 | $599.00K derived: sum of 3 quarters · filed 2024-03-29 | $1.32M 10-K · filed 2024-03-29 | |
| 2022-09-30 | $338.00K 10-Q · filed 2023-11-13 | $589.00K derived: sum of 2 quarters · filed 2023-11-13 | $1.31M 10-Q · filed 2023-11-13 | $3.74M derived: sum of 4 quarters · filed 2023-11-13 | |
| 2022-06-30 | $251.00K 10-Q · filed 2023-08-04 | $970.00K 10-Q · filed 2023-08-04 | $3.40M derived: sum of 3 quarters · filed 2023-08-04 | $5.08M derived: sum of 4 quarters · filed 2023-08-04 | |
| 2022-03-31 | $719.00K 10-Q · filed 2023-05-09 | $3.15M derived: sum of 2 quarters · filed 2023-05-09 | $4.83M derived: sum of 3 quarters · filed 2023-05-09 | $6.49M derived: sum of 4 quarters · filed 2023-05-09 | |
| 2021-12-31 | $2.43M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-03 | $4.11M derived: sum of 2 quarters · filed 2023-03-03 | $5.77M derived: sum of 3 quarters · filed 2023-03-03 | $7.35M 10-K · filed 2023-03-03 | |
| 2021-09-30 | $1.68M 10-Q · filed 2022-11-08 | $3.33M derived: sum of 2 quarters · filed 2022-11-08 | $4.92M 10-Q · filed 2022-11-08 | $6.34M derived: sum of 4 quarters · filed 2022-11-08 | |
| 2021-06-30 | $1.66M 10-Q · filed 2022-08-11 | $3.24M 10-Q · filed 2022-08-11 | $4.66M derived: sum of 3 quarters · filed 2022-08-11 | $6.09M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | $1.58M 10-Q · filed 2022-05-16 | $3.00M derived: sum of 2 quarters · filed 2022-05-16 | $4.43M derived: sum of 3 quarters · filed 2022-05-16 | $6.12M derived: sum of 4 quarters · filed 2022-05-16 | |
| 2020-12-31 | $1.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $2.85M derived: sum of 2 quarters · filed 2022-03-29 | $4.54M derived: sum of 3 quarters · filed 2022-03-29 | $5.98M 10-K · filed 2022-03-29 | |
| 2020-09-30 | $1.43M 10-Q · filed 2021-11-15 | $3.12M derived: sum of 2 quarters · filed 2021-11-15 | $4.56M 10-Q · filed 2021-11-15 | $6.91M derived: sum of 4 quarters · filed 2021-11-15 | |
| 2020-06-30 | $1.69M 10-Q · filed 2021-08-05 | $3.13M 10-Q · filed 2021-08-05 | $5.48M derived: sum of 3 quarters · filed 2021-08-05 | $6.92M derived: sum of 4 quarters · filed 2021-08-05 | |
| 2020-03-31 | $1.44M 10-Q · filed 2021-05-05 | $3.79M derived: sum of 2 quarters · filed 2021-05-05 | $5.24M derived: sum of 3 quarters · filed 2021-05-05 | $6.15M derived: sum of 4 quarters · filed 2021-05-05 | |
| 2019-12-31 | $2.35M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $3.79M derived: sum of 2 quarters · filed 2021-02-25 | $4.70M derived: sum of 3 quarters · filed 2021-02-25 | $5.45M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $1.44M 10-Q · filed 2020-11-05 | $2.35M derived: sum of 2 quarters · filed 2020-11-05 | $3.10M 10-Q · filed 2020-11-05 | $3.78M derived: sum of 4 quarters · filed 2020-11-05 | |
| 2019-06-30 | $911.00K 10-Q · filed 2020-08-06 | $1.65M 10-Q · filed 2020-08-06 | $2.33M derived: sum of 3 quarters · filed 2020-08-06 | $2.44M derived: sum of 4 quarters · filed 2020-08-06 | |
| 2019-03-31 | $743.00K 10-Q · filed 2020-05-07 | $1.42M derived: sum of 2 quarters · filed 2020-05-07 | $1.53M derived: sum of 3 quarters · filed 2020-05-07 | $1.63M derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | $681.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-12 | $784.00K derived: sum of 2 quarters · filed 2020-02-12 | $887.00K derived: sum of 3 quarters · filed 2020-02-12 | $988.00K 10-K · filed 2020-02-12 | $905.00K 10-K · filed 2019-03-12 |
| 2018-09-30 | $103.00K 10-Q · filed 2019-11-07 | $206.00K derived: sum of 2 quarters · filed 2019-11-07 | $307.00K 10-Q · filed 2019-11-07 | $408.00K derived: sum of 4 quarters · filed 2019-11-07 | |
| 2018-06-30 | $103.00K 10-Q · filed 2019-08-06 | $205.00K 10-Q · filed 2019-08-06 | $305.00K derived: sum of 3 quarters · filed 2019-08-06 | $405.00K derived: sum of 4 quarters · filed 2019-08-06 | |
| 2018-03-31 | $102.00K 10-Q · filed 2019-05-09 | $202.00K derived: sum of 2 quarters · filed 2019-05-09 | $302.00K derived: sum of 3 quarters · filed 2019-05-09 | $402.00K derived: sum of 4 quarters · filed 2019-05-09 | |
| 2017-12-31 | $100.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $200.00K derived: sum of 2 quarters · filed 2019-03-12 | $300.00K derived: sum of 3 quarters · filed 2019-03-12 | $396.00K 10-K · filed 2019-03-12 | |
| 2017-09-30 | $100.00K 10-Q · filed 2018-11-08 | $200.00K derived: sum of 2 quarters · filed 2018-11-08 | $296.00K 10-Q · filed 2018-11-08 | ||
| 2017-06-30 | $100.00K 10-Q · filed 2018-08-09 | $197.00K 10-Q · filed 2018-08-09 | |||
| 2017-03-31 | $97.00K 10-Q · filed 2018-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |